Search
Now showing items 131-135 of 135
Proscar: five-year experience
(Elsevier, 1995)
We assessed the long-term safety and efficacy of finasteride, an orally
active 5 alpha-reductase inhibitor, in 2 previously reported groups of
patients with symptomatic benign prostatic hyperplasia (BPH). Prostate
volume was measured by magnetic resonance imaging, and the maximum urinary
flow rate ...
Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment
(Endocrine Society, 2004-01)
This study aimed to establish whether the degree of suppression of serum
FSH and LH was related to sperm concentration in three testosterone (T)
plus progestin contraceptive regimens. We measured serum FSH and LH using
a modified, highly sensitive immunofluorometric assay in samples obtained
from ...
A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive
(Endocrine Society, 1996-08)
In this study we tested the effectiveness of the combined administration
of cyproterone acetate (CPA) and testosterone enanthate (TE) in
suppressing spermatogenesis. After a control phase of 3 months, 15 normal
men were randomized to receive TE (100 mg/week) plus CPA at a dose of 100
mg/day (CPA-100; ...
The induction of premature luteolysis in normal women--follicular phase luteinizing hormone secretion and corpus luteum function in the subsequent cycle
(Elsevier, 1991-04)
Women with luteal phase deficiency have been shown to have an increased
frequency of luteinizing hormone pulses in the early follicular phase of
the menstrual cycle. Because progesterone is known to modulate luteinizing
hormone secretion, it has been hypothesized that the decreased
progesterone ...
Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone
(Endocrine Society, 1986-01)
The reduction of circulating levels of gonadotropins and testosterone is
of value for the treatment of steroid-dependent neoplasms and the control
of fertility. We tested the ability of single and multiple doses of the
GnRH antagonist [N-Ac-D-Nal(2)1, D-pCl-Phe2, D-Trp3, D-hArg(Et2)6,
D-Ala10]GnRH ...